2945sek
-2,8 %
Date:2024-05-02Time:10:11:57Latest report:Q1-2024List:First NorthTicker:VIMIAN
Market Cap:15 411 msekEnterprise Value:18 565 msekNet Sales:334,9 meurEarnings:7,47 meurEmployees:0ISIN:SE0015961982

Ratios

10-year key figure history for Vimian Group turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Vimian Group with index and moving average MA50 and MA200.

Stockprice:29,45
MA50:30,59
MA200:27,69
Price/MA200:6,5 %
RSI (14):43,7
Price/MA50:-3,6 %

Description

Vimian is a global and diversified animal health group. The Company offers a broad portfolio of products and services to the companion animal and livestock health markets. The Group operates under four brands, targeting fourverticals of the animal health market. Specialty Pharma-Nextmune, Nextmune is a global provider of proprietary diagnostics, prescription and non-prescription treatments for treatment of chronic conditions and preventive care for companion animals. Diagnostics-Indical Bioscience. Indical Bioscience is a leading provider of molecular and immunodiagnostic Solutions primarily used by laboratories for veterinary specific applications, with a focus on both the livestock and companion animal health markets. Veterinary Services- VetFamily. VetFamily is a membership-based service platform for veterinary clinics.